Riskpilot← Back to searchSign inGet full accessBioGroup A/S
A/SActiveCVR 36549726Baldersbuen 43Wholesale of china and glassware and cleaning materials · NACE 4644Est. 20154 employeeswww.biogroup.dk
Revenue 2024
DKK 242K
-637% vs 2023
EBITDA margin
-527.4%
+23% vs 2023
Equity ratio
-1700.4%
Financial strength
Net profit 2024
DKK -1,6M
+16% vs 2023
| Revenue | DKK 242K | -637% |
| EBITDA | DKK -1,3M | +23% |
| Net profit | DKK -1,6M | +16% |
| Total assets | DKK 394K | -36% |
| Equity | DKK -6,7M | -31% |
| Employees | 4 | — |
Legal name
BioGroup A/S
CVR number
36549726
Legal form
Aktieselskab
NACE code
4644 · Wholesale of china and glassware and cleaning materials
Founded
19. februar 2015
Share capital
DKK 500.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og bestyrelsesformanden i forening, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at være et handelsselskab, herunder engroshandel, samt anden dermed beslægtet virksomhed.
Address
Baldersbuen 43
Phone
+4542901010
Email
jp@biogroup.dk
Website
www.biogroup.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1.294 | 322 | 117 | -45 | 242 |
| Staff expenses | -905 | -998 | -1.432 | -1.609 | -1.517 |
| EBITDA | 389 | -676 | -1.316 | -1.654 | -1.275 |
| Depreciation & amort. | -7 | -16 | -23 | -45 | -45 |
| EBIT | 382 | -691 | -1.339 | -1.699 | -1.320 |
| Net financials | -73 | -87 | -122 | -179 | -255 |
| Profit before tax | 309 | -778 | -1.461 | -1.878 | -1.575 |
| Tax | 68 | -171 | 320 | -0 | -0 |
| Net profit | 240 | -607 | -1.781 | -1.878 | -1.575 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2.598 | 1.070 | 679 | 616 | 394 |
| Equity | -865 | -1.472 | -3.254 | -5.132 | -6.707 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3.463 | 2.542 | 3.932 | 5.747 | 7.101 |
| Total debt | 3.463 | 2.542 | 3.932 | 5.747 | 7.101 |
EBITDA margin
-527.4%
This company
15.8%
Market median
-3438% vs market
20202024
Equity ratio
-1700.4%
This company
38.2%
Market median
-4551% vs market
20202024
Return on equity
-157508300.0%
This company
18.4%
Market median
-856023470% vs market
20202024
Net profit margin
-651.4%
This company
8.1%
Market median
-8142% vs market
20202024
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20202024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JH Founder | Founder | 2015 |
JP Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2022 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2020 | |
| Company | 20–24.99% | 20–24.99% | 2022 | |
| Individual | 25–33.32% | 25% | 2016 | |
| Company | 5–9.99% | 5–9.99% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EXAPIO ApS
BioGroup A/S Board members of BioGroup A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørn Hedemand | Founder | 0 companies |
| Jesper Philipp | Chief Executive Officer | 0 companies |
| Nicolaj Løndahl Nielsen | Chairman | 0 companies |
| Peter Roulund | Board of Directors | 0 companies |